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The mineralocorticoid receptor (MR), a member of
the steroid receptor superfamily, regulates water-
electrolyte balance andmediates pathophysiological
effects in the renocardiovascular system. Previously,
it was assumed that after binding aldosterone, the
MR dissociates from HSP90, forms homodimers,
and then translocates into the nucleus where it acts
as a transcription factor (Guiochon-Mantel et al.,
1989; Robertson et al., 1993; Savory et al., 2001).
We found that, during aldosterone-induced nuclear
translocation, MR is bound to HSP90 both in the
cytosol and the nucleus. Homodimerization mea-
sured by eBRET and FRET takes place when the
MR is already predominantly nuclear. In vitro binding
ofMR toDNAwas independent of ligand but could be
partially inhibited by geldanamycin. Overall, here we
provide insights into classical MR signaling neces-
sary for elucidating the mechanisms of pathophysio-
logical MR effects and MR specificity.
INTRODUCTION
Steroid receptors are ligand-dependent intracellular receptors
belonging to the nuclear receptor superfamily comprising the
progesterone, estrogen, androgen, glucocorticoid, and mineral-
ocorticoid receptor (MR). They possess a common structure
with six domains A–F. The N-terminal A/B domain is the most
variable among the receptors and contains an autonomous acti-
vation function. The C domain is highly conserved and pos-
sesses a DNA-binding domain with two zinc fingers. It is followed
by a hinge region, D, and a carboxy-terminal ligand-binding
domain. Previously, the MR with its classical role in water-
electrolyte and blood pressure homeostasis was the least appre-
ciated member of the steroid receptors. New interest in MR
arose when clinical studies suggested that MR antagonists are
beneficial for patients with cardiac remodeling and renal disease
(Chrysostomou et al., 2006; Pitt et al., 2003). Since then,MR acti-
vation has been shown to be involved in a variety of pathophys-
iological effects in the renocardiovascular system including
endothelial dysfunction, inflammation, hypertrophy, and fibrosis
in animal experiments (Blasi et al., 2003; Brilla and Weber, 1992;
Sarto´rio et al., 2007). The exact mechanisms for these MR
effects are still unclear.742 Chemistry & Biology 19, 742–751, June 22, 2012 ª2012 ElsevierThe classical view is that MR resides in the cytoplasm in its
unliganded form coupled to chaperone molecules like HSP90
(Sanchez et al., 1985). The interaction with HSP90 is a prerequi-
site for stabilization of the ligand-binding structure of the MR
(Nemoto et al., 1993). Upon binding of ligand, the MR undergoes
a conformational change and HSP90 dissociates from the re-
ceptor (Couette et al., 1998; Hellal-Levy et al., 2000). With the
help of nuclear localization signals (NLSs), the MR is then trans-
ported to the nucleus (Piwien Pilipuk et al., 2007; Walther et al.,
2005). After nuclear translocation, MR binds to hormone re-
sponse elements as a homodimer and regulates the expression
of its target genes (Drouin et al., 1992; Tsai et al., 1988; Wrange
et al., 1989). The glucocorticoid receptor (GR) binds to the same
hormone response elements (glucocorticoid response element;
GRE) but nevertheless elicits different effects (Arriza et al.,
1987). Recently, HSP90-dependent trafficking of steroid recep-
tors was suggested, and an interaction between steroid recep-
tors and molecular chaperones with nuclear pore components
was demonstrated (Echeverrı´a et al., 2009; Galigniana et al.,
2010). Our aimwas to elucidate themechanism of MR transloca-
tion, dimerization, and DNA binding further and thereby extend
the understanding of MR signaling.
RESULTS
Localization of MR in the Cell
To determine the localization of the MR in the cell, a fusion
protein between MR and enhanced green fluorescent protein
(EGFP) was utilized. HEK cells were transfected with this con-
struct and localization of MRwas tested by fluorescencemicros-
copy 1.5 hr after incubation with either vehicle (DMSO), 10 nM
aldosterone (MR agonist), 100 nM spironolactone (MR antag-
onist), 4 mM geldanamycin (HSP90 inhibitor), or 10 nM aldoste-
rone with 4 mM geldanamycin (Figure 1A).
Unstimulated MR was predominantly located in the cytosol
and resided in this location after incubation with spironolactone,
geldanamycin alone, or geldanamycin + aldosterone. After incu-
bation with 10 nM aldosterone, MR was mainly detected in the
nucleus.
Translocation of MR to Nucleus and HSP90
Aldosterone-induced translocation of the MR into the nucleus
wasmeasured by time lapse recordings (Figure 1B). At a temper-
ature of 37C, a rapid translocation of the MR was visible with
a half-life (T1/2) = 6.9 min (Figure 1C).
To verify that HSP90 is not only located in the cytosol but also
in the nucleus, we detected HSP90 in MR-transfected HEK cellsLtd All rights reserved
Figure 1. Localization of MR in Cell
(A) Localization of EGFP-hMR was detected by
fluorescence microscopy in HEK293 cells tran-
siently transfected with EGFP-hMR and incubated
with vehicle (DMSO 1:1000), 10 nM aldosterone
(aldo), 100 nM spironolactone (spiro), 4 mM gel-
danamycin (geldana), or 4 mM geldanamycin +
10 nM aldosterone (aldo + geldana) for 1.5 hr.
(B) For further information about the time course of
the cytoplasmic-nuclear shuttling, transiently
transfected EGFP-MR-HEK cells were incubated
with 10 nM aldosterone and time lapse recordings
were performed in an incubation chamber at 37C.
(C) Increase in average intensity of the nucleus
wasmeasured in EGFP-MR-transfected HEK cells
after incubation with 10 nM aldosterone (n = 10;
data presented as mean ± SEM).
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MR-Nuclear Shuttling Precedes Dimerizationby immunofluorescence staining (Figure 2A). Cells shown were
incubated with 10 nM aldosterone, but no visible difference in
HSP90 distribution was found between aldosterone-stimulated
or -unstimulated cells. These results were confirmed by western
blot experiments in rigorously washed cytosolic and nuclear cell
extracts ofMR- andGR-transfected HEK cells (Figure 2B). These
data show that HSP90 is not only located in the cytosol but also,
to a lesser degree, in the nucleus. MR activation did not lead to
a gross redistribution of HSP90.
To investigate the role of the chaperone HSP90 for MR nuclear
translocation, we transfected HEK cells with EGFP-MR, immu-
noprecipitated the MR by its EGFP tag, and then detected coim-
munoprecipited HSP90 by western blot. In whole cell lysates of
unstimulated cells, MR was associated with HSP90. After incu-
bation with aldosterone, the amount of coimmunoprecipitated
HSP90 stayed unchanged within the first 6 min and then rapidly
decreased to a minimum of 17% ± 5% after 30 min compared to
cells without aldosterone stimulation. During the first 6 min of
aldosterone incubation, nuclear translocation reached its half-
maximal values while HSP90-MR coimmunoprecipitation was
still unchanged. When immunoprecipitating the EGFP-MR in
nuclear extracts and then detecting HSP90, the amount of
MR-HSP90 complexes detected in nuclear extracts was not
reduced but even enhanced (1.8-fold) after 6 min incubation
with aldosterone compared to incubation without ligand as
shown in a representative blot in Figure 2D. These data suggest
that HSP90 does not dissociate fromMR directly after its binding
of aldosterone but that HSP90 is still attached to the MR when
the MR enters the nuclear compartment.
Homodimerization of MR
The traditional GRE consists of 15 base pairs (bp) with an
inverted repeat structure: 50-AGRACAnnnTGTYCT-30. Binding
of MR to DNA classically involves formation of homo-
dimers. To investigate MR homodimerization in vivo and in real
time, we established an extended bioluminescence resonanceChemistry & Biology 19, 742–751, June 22, 2012energy transfer (BRET) system (eBRET)
for monitoring MR-MR interactions. MR
was coupled to either renilla luciferase
or enhanced yellow fluorescent protein
(EYFP). Four stably transfected pRLuc-MRHEK cell clones were chosen for further eBRET experiments.
To optimize the amount of transiently transfected pEYFP-MR in
our eBRET measurements, we determined BRET ratios for
different concentrations of pEYFP-hMR when incubating cells
with either vehicle or 10 nM aldosterone (Figure S1A available
online). To exclude accumulation and unspecific interactions of
proteins, we alsomeasured BRET ratios for stable pRLuc (vector
only) HEK clones with comparable concentrations of EYFP-MR
(Figure S1B). With the optimized MR-MR eBRET system, we
then measured BRET ratios after incubation with 10 nM aldoste-
rone and compared them to the changes induced by the compet-
itive MR antagonist spironolactone (Figure 3A). Aldosterone
caused a significant increase in BRET ratio within the first
15 min of incubation, suggesting that MR-MR dimerization
commences at this time point. Incubation with 100 nM spirono-
lactone did not lead to an increase in BRET ratio, indicating that
spironolactone does not induce MR homodimerization. Addi-
tional eBRET experiments were performed with geldanamycin
(Figure 3B). It is interesting that BRET ratios increased within
15 min to levels comparable to those obtained after incubation
with aldosterone. These results suggest that binding of the MR
to HSP90 prevents MR dimerization and that dissociation from
HSP90 enables MRs to come into close vicinity of one another,
forming spontaneous homodimers even in the absence of
aldosterone.
To gain information about the localization of the MR-MR
dimerization, we correlated eBRET results with fluorescence
microscopy and time lapse experiments. Nuclear translocation
of MR occurred rapidly with T1/2 = 6.9 min (Figure 1C). The
eBRET measurements show that homodimerization occurs
within the first 15 min. For more rapid measurements, fluores-
cent resonance energy transfer (FRET) between EYFP-MR
(excitation/emission maxima, 514 nm/527 nm) and RFP-MR
(excitation/emission maxima, 558 nm/583 nm) was utilized (Fig-
ure 4A). The function of the generated fusion proteins for BRET
and FRET was ensured by reporter gene assays and optionallyª2012 Elsevier Ltd All rights reserved 743
Figure 2. HSP90 and Nuclear Translocation of MR
(A) Transiently MR-transfected HEK cells were incubated with 10 nM aldosterone for 30 min. Immunofluorescent staining against HSP90 with Oregon Green
secondary antibody was performed (middle) with additional DAPI staining to indicate the nuclei (right). Incubation with only secondary antibody did not lead to
staining of cells (left). Images are taken from z-stacks obtained with a BZ-8000 microscope.
(B) HEK cells transiently transfected with MR or GR plasmid were incubated for 1 hr with DMSO (unstimulated) or 10 nM aldosterone for MR/100 nM dexa-
methasone for GR (stimulated). A cytosolic and a nuclear cell fraction were obtained, and western blotting against HSP90 was performed.
(C) Coimmunoprecipitation experiments of EGFP-MR-transfected HEK cells with EGFP-MR pulldown and subsequent HSP90 immunoblotting were performed
with whole cell lysates after incubating the cells for different time points with 10 nM aldosterone. HSP90 was quantified densitometrically and depicted as
percentage of unstimulated control incubated with vehicle alone. In the same graph, the percentage of nuclear MR shuttling after stimulation with 10 nM
aldosterone is shown for different time points assessed by fluorescent microscopy of EGFP-tagged MR (data presented as mean ± SEM).
(D) Coimmunoprecipitation experiments of EGFP-MR-transfected HEK cells with EGFP-MR pulldown and subsequent HSP90 and MR immunoblotting were
performedwith nuclear extracts after incubating the cells for 6minwith vehicle or 10 nM aldosterone. A typical experiment is shown suggesting that the amount of
MR-associated nuclear HSP90 increases after incubation with aldosterone.
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MR-Nuclear Shuttling Precedes Dimerizationdisplacement experiments (Figure S2). Within the first 10 min, no
significant FRET ratio could be quantified. After 15 min and
60 min, FRET ratios indicating MR-MR dimerization were signif-
icantly increased. At this time, the MR has already translocated
into the nucleus according to our time lapse experiments, sup-
porting that homodimerization occurs in the nucleus. This was
confirmed by single-cell FRET experiments, which show a posi-
tive FRET in the nucleus after incubation with aldosterone (Fig-
ure 4B). The HSP90 inhibitor geldanamycin also increased the
FRET ratio compared to vehicle (Figure 4A). This indicates that
MR dimerization is triggered by the dissociation of MR from
HSP90—either in the nucleus by providing DNA for binding or
in the cytosol promoted by geldanamycin.
Binding of MR to GRE
To investigate DNA binding of activated receptor, we applied
a transcription factor ELISA with biotinylated GRE. In vitro trans-
lation of mineralocorticoid receptor, glucocorticoid receptor,
and beta-galactosidase (Lacz) as negative control was per-
formed in reticulocyte lysates. As assessed by western blot,744 Chemistry & Biology 19, 742–751, June 22, 2012 ª2012 Elseviersimilar amounts of receptor were translated (Figure 5A). In the
transcription factor ELISA, MR and GR displayed comparable
binding capacities at their response element GRE (Figure 5B).
Next, we compared binding of MR and GR to GRE in the pres-
ence and absence of their respective ligands, aldosterone and
dexamethasone (Figure 5C). Neither binding of MR nor that of
GR was dependent on the presence of ligand. Because reticulo-
cyte lysates contain HSP90 and we previously observed that
HSP90 can be found in the nucleus, we investigated the effect
of HSP90 on the binding of MR and GR to GRE (Figure 5D). No
binding of HSP90 could be detected in MR-GRE or GR-GRE
complexes (Figure 5E). Incubation with geldanamycin had no
effect on binding of GR to GRE but significantly reduced binding
of MR to GRE to 66 ± 8% of control (Figure 5F). To show that this
effect is not mediated by enhanced protein degradation of the
MR, western blots were performed and provided no evidence
for enhanced MR or GR degradation by 1 hr incubation with
geldanamycin. Thus, binding of MR or GR to DNA does not
seem to involve recruitment of HSP90 to the DNA; however,
binding of MR, but not GR, to GRE appears to be facilitated byLtd All rights reserved
Figure 3. BRET of MR-MR
BRET ratios were determined for stably pRLuc-
hMR-expressing HEK293 clones transiently tran-
sfected with pEYFP-MR. Cells were preincubated
with 60 mM Enduren and then incubated with
vehicle, 10 nM aldosterone, or 100 nM spi-
ronolactone (A) or with 4 mM geldanamycin (B) for
90 min at 37C (n = 11–33 for each time interval;
data are presented as mean ± SEM; *p < 0.05).
See also Figure S1.
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MR-Nuclear Shuttling Precedes DimerizationHSP90. This marks a difference between MR and GR that could
be involved in the different effects of MR and GR at the GRE.
Transactivation of MR
Although translocation of MR to the nucleus, dimerization, and
binding to GRE are all necessary for the function of the MR,
they do not automatically lead to a transactivation. To test the
actual transactivation of MR and GR, we used a reporter gene
assay. As expected, transactivation of MR can be achieved by
10 nM aldosterone while GR is activated by 100 nM dexameth-
asone. Disrupting the function of HSP90 by incubation with gel-
danamycin prevented MR and GR transactivation in HEK cells
(Figures 6A and 6B). These data suggest that the nuclear
receptor dimers occurring in the cytoplasm in the presence of
geldanamycin are not functionally active because they cannot
be transported into the nucleus without HSP90. Dissociation of
HSP90 is a prerequisite for dimerization, but transactivationChemistry & Biology 19, 742–751, June 22, 2012can only occur if the dimers are formed
in the nucleus because otherwise nuclear
transport is not possible.
To exclude enhanced degradation of
MR caused by geldanamycin, MR levelsof unstimulated andaldosterone-stimulated cellswere quantified
after 24 hr and 48 hr in the presence and absence of geldanamy-
cin. Geldanamycin had no visible effect on MR protein levels. Of
note, incubation of cells with aldosterone led to an increased
smear of the MR bands, suggesting an increase in posttransla-
tional modifications of the stimulated MR. This change did not
occur in the presence of aldosterone plus geldanamycin.
DISCUSSION
In the absence of ligand, the MR is predominantly located in the
cytosol (Nishi et al., 2004; Piwien Pilipuk et al., 2007). Some
groups also describe an equal distribution of MR between
cytosol and nucleus in heterologous expression systems
(Fejes-To´th et al., 1998; Nishi et al., 2001; Walther et al., 2005).
Additionally, constitutive nuclear localization was postulated
in cardiomyocytes, suggesting a cell-type-specific behaviorFigure 4. FRET of MR-MR
(A) To investigate the time course of dimerization in
more detail, we performed FRET experiments in
96-well plates with RFP-MR and EYFP-MR trans-
fected HEK cells after 0, 3, 10, 15, and 60 min
incubation with aldosterone and after 60 min
incubation with geldanamycin (n = 6; N = 3; data
are presented as mean ± SEM; *p < 0.05) (top).
Scheme of FRET experiment (bottom).
(B) FRET index images were acquired from single
cells incubated with vehicle or 10 nM aldosterone
for 1 hr. EYFP shows the donor emission after
excitation of EYFP; RFP shows the acceptor
emission after excitation of RFP. FRET displays
the intensities of acceptor emission due to FRET
with blue indicating no FRET and red indicating
high FRET.
See also Figure S2.
ª2012 Elsevier Ltd All rights reserved 745
Figure 5. GRE Binding of MR/HSP90
(A) In vitro translation of MR, GR, and Lacz (negative control) was performed in reticulocyte lysates, and the resulting protein concentrations were compared by
western blot with an antibody against a common Xpress tag.
(B) Binding capacities of in-vitro-translated MR, GR, and Lacz to GRE were compared in a transcription factor binding assay in the presence of the respective
hormone receptor ligands aldosterone or dexamethasone (n = 9–13, N = 5–7; data are presented as mean ± SEM; *p < 0.05).
(C) Binding of in-vitro-translated MR, GR, and negative control Lacz to the glucocorticoid response element was assessed in a transcription factor binding assay
in the presence or absence of the respective hormone receptor ligands aldosterone or dexamethasone (n = 8; N = 4; data presented as mean ± SEM; *p < 0.05).
(D) Reticulocyte lysates used for in vitro translation also contain HSP90 as shown here by western blot.
(E) Direct or indirect binding of HSP90 to GRE was tested in our GRE transcription factor ELISA with anti-HSP90 after incubating in vitro MR and GR in the
presence or absence of 2 mM geldanamycin with biotinylated GRE (n = 6; N = 4; data are presented as mean ± SEM).
(F) The influence of HSP90 on hormone receptor DNA binding was investigated by testing the binding of MR and GR to GRE in the presence and absence of 2 mM
geldanamycin (incubation time, 1 hr) (n = 8–12; N = 4–6; data are presented as mean ± SEM; *p < 0.05). Insert: Representative western blot showing in-vitro-
synthesized MR and GR incubated with 2 mM geldanamycin or vehicle for 1 hr.
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MR-Nuclear Shuttling Precedes Dimerization(Herna´ndez-Dı´az et al., 2010). The MR is associated with chap-
erones including HSP90, HSP70, and p23 and various immuno-
philins like FKBP51 (Galigniana et al., 2010; Sanchez et al.,
1985). By binding to its chaperones, the MR is kept in a confor-
mation that is able to bind aldosterone, and it is also prevented
from rapid degradation (Binart et al., 1995; Caaman˜o et al.,
1993). In agreement with our findings, aldosterone rapidly
induces translocation of the MR into the nucleus under physio-
logical conditions, i.e., 37C and pH 7.4 (Fejes-To´th et al.,
1998; Piwien Pilipuk et al., 2007; Walther et al., 2005). Variations
in the reported time courses can be attributed to different condi-
tions because trafficking is, for example, highly dependent on
incubation temperature (Nishi et al., 2004). Rapid nuclear trans-
location of MR is thought to be dependent on the NLS regions of
the MR. So far, three potential NLS have been identified and
a mechanisms involving importin-alpha has been proposed for
penetrating the nuclear envelope (Pearce et al., 2002; Tanaka
et al., 2005; Walther et al., 2005). Both NLS0 and NLS1 have
been shown to be required for aldosterone-induced nuclear
translocation of MR (Herna´ndez-Dı´az et al., 2010), although
a slower additional NLS1-independent mechanism has also
been postulated (Piwien Pilipuk et al., 2007). On the contrary,746 Chemistry & Biology 19, 742–751, June 22, 2012 ª2012 Elseviernuclear export takes several hours after steroid withdrawal for
the GR and has not been addressed in detail for the MR, with
Walther et al. even suggesting a unidirectional transport of MR
to the nucleus (Galigniana et al., 1999; Savory et al., 1999;
Walther et al., 2003).
Previously, it was hypothesized that binding of ligand causes
dissociation of MR from HSP90 and thereby unmasking of NLS
with associated nuclear translocation (Picard and Yamamoto,
1987; Walther et al., 2005). This was challenged by experiments
showing that mutants without NLS but associated with a NLS-
containing-HSP90 also get transported into the nucleus (Kang
et al., 1994). Simultaneously, several investigators found that
HSP90 is not exclusively located in the cytoplasm but also in
the nucleus (Galigniana et al., 2010; Herna´ndez-Dı´az et al.,
2010). Accordingly, we detected HSP90 in the nucleus when
performing western blots with cell fractions and in z-stack
images of immunofluorescence images. Our findings are sup-
ported by data suggesting that binding of ligand does not cause
dissociation of MR from HSP90 but rather a shift in attached
proteins from FKBP51 to FKBP52. FKBP52 then creates a link
to dynein/dynactin motor proteins, which propagate nuclear
translocation (Banerjee et al., 2008; Galigniana et al., 2010).Ltd All rights reserved
Figure 6. MR Transactivation Activity
(A) Transactivation activity was assessed in
a GRE-SEAP reporter gene assay. HEK cells were
transfected with MR and incubated for 48 hr with
vehicle (control), 10 nM aldosterone, 2 mM gelda-
namycin, or a combination of 10 nM aldosterone
and 2 mM geldanamycin (n = 9; N = 3; data pre-
sented as mean ± SEM; *p < 0.05).
(B) Transactivation activity was assessed in a
secreted alkaline phosphatase (SEAP)-GRE re-
porter gene assay. HEK cells were transfectedwith
GR and incubated for 48 hr with vehicle (control),
100 nM dexamethasone, 2 mM geldanamycin, or
a combination of 100 nM dexamethasone and
2 mM geldanamycin (n = 9; N = 3; data are pre-
sented as mean ± SEM; *p < 0.05).
(C) Western blot analyses of MR in HEK cells
transfected with EGFP-MR and incubated with
vehicle (DMSO) or 10 nM aldosterone in either the
presence or the absence of 2 mM geldanamycin
were performed (n = 3).
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MR-Nuclear Shuttling Precedes DimerizationThis matches our own findings that HSP90 can be coimmuno-
precipitated with MR from nuclear extracts and that when 50%
of the MR has already translocated into the nucleus, the amount
of HSP90 association withMR in cell lysates is still at amaximum
level (Figure 2C). Nevertheless, colocalization of MR and HSP90
in the cytoplasm and the nucleus does not prove entirely but
suggests that both molecules travel through the nuclear pore
together. Alternatively, cytosolic HSP90 could also transport
the MR to the nuclear pore, and nuclear HSP90 could then
receive the MR after it has entered the nucleus. At present, these
two options cannot be distinguished, whereas we regard the first
option as more likely.
Formation of homodimers by steroid receptors has been well
documented by several authors (Drouin et al., 1992; Tsai et al.,
1988; Wrange et al., 1989). Furthermore, formation of hetero-
dimers between MR and GR has been demonstrated, although
the physiological relevance is still unclear (Liu et al., 1995; Nishi
et al., 2004; Savory et al., 2001). However, the time point and
localization of homodimer formation, i.e., whether the associa-
tion takes place in the cytosol or the nucleus, is still under
debate. Based on GR and progesterone receptor DNA-binding
experiments, a model involving dimerization prior to binding of
DNA is favored in literature instead of consecutive binding of
monomers to DNA (Segard-Maurel et al., 1996; Tsai et al.,
1988). One reason for this is the lower affinity to DNA of GR
monomers compared to dimers (Tsai and O’Malley, 1994).
With eBRET analysis, we found that aldosterone leads to MR
dimerization within 15 min. To receive data for earlier time points
with clear cytoplasmic MR localization, we additionally con-Chemistry & Biology 19, 742–751, June 22, 2012ducted FRET experiments. We observed
an increase in FRET ratio after addition
of aldosterone, which reached signifi-
cance only after 15 min, a time point at
which the MR is already predomi-
nantly nuclear according to our fluores-
cence microscopy experiments. Single-
cell FRET experiments also indicate that
dimerization occurs in the nucleus. Thiscorrelates with the exclusive nuclear heterodimerization of MR
and GR reported by Nishi et al. (2004), applying FRET analysis
in cultured hippocampal neurons and COS-1 cells after incuba-
tion with corticosterone. Additionally, GR mutants lacking the
NL1 region were not able to translocate into the nucleus when
coexpressed with intact MR, suggesting that heterodimerization
does not occur in the cytosol. Savory et al. (2001) came to
a somewhat different conclusion in COS7 cells after dexameth-
asone stimulation. They observed that more cells show a
predominantly nuclear localization of GR-NLS1 mutants when
MR is cotransfected simultaneously and suggested that this
behavior can be explained by cytoplasmic dimerization. How-
ever, it could also be explained by stronger nuclear retention of
GR after binding to MR in the nucleus. Furthermore, these differ-
ences could also be due to differences in experimental setup or
might reflect an actual difference between GR and MR homo-
dimers and heterodimers.
As a substance that influences steroid receptor function, the
antibiotic geldanamycin was investigated in our eBRET system.
Geldanamycin mediates its effects by binding with high speci-
ficitywithin theADP/ATPbindingpocket ofHSP90, thereby inhib-
iting the function of HSP90 (Stebbins et al., 1997). Previously, it
hasbeen reported that geldanamycin hinders folding and thereby
steroid binding activity of steroid receptors. In addition, HSP90
binding to receptor is impaired; therefore, degradation of steroid
receptors is enhanced (Czar et al., 1997; Smith et al., 1995;
Whitesell and Cook, 1996). Both a lack of and a slowing down of
nuclear translocation have also been reported, aswell as a loss in
transactivation activity (Bamberger et al., 1997; Czar et al., 1997).ª2012 Elsevier Ltd All rights reserved 747
Figure 7. Model of Genomic MR Activation
Unstimulated MR resides in the cytosol bound to HSP90 (1). Aldosterone can
bind to HSP90-bound MR, which then translocates into the nucleus together
with HSP90 (2). In the nucleus, HSP90 dissociates from the MR, which then
forms homodimers and binds to DNA (3). Alternatively, geldanamycin can
inhibit HSP90 function, which causes the MR to form homodimers in the
cytosol (4). These homodimers without HSP90 are not able to translocate into
the nucleus and increase GRE activity (5).
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MR-Nuclear Shuttling Precedes DimerizationWe used geldanamycin as an HSP90 inhibitor to depict the
functional importance of HSP90 for trafficking and function of
MR. We could show that HSP90 inhibition prevents aldoste-
rone-induced nuclear translocation of the MR (Figure 1A), leads
to spontaneous cytosolic dimerization of MR without aldoste-
rone as measured by BRET and FRET (Figures 3B and 4A),
partially inhibits DNA binding of MR but not GR (Figure 5F),
and prevents transactivation of MR at a GRE element (Figure 6A).
These results are in agreement with our model, in which MR is
kept out of the nucleus without HSP90 even in the presence of
aldosterone (Figure 1A). For MR, HSP90 also seems to further
overall DNA binding.
Previously, analyses by fluorescence recovery after photo-
bleaching (FRAP) and chromatin immunoprecipitation experi-
ments suggest that binding of steroid hormone receptors to their
promoter elements involves rapid cycling, perhaps with the rate
of exchange influencing transcriptional levels. HSP90 has been
shown either to initiate disassembly of the receptor from the
promoter and the transcriptional regulatory complex or to stabi-
lize binding of receptor to the promoter and thereby modify the
receptor cycling at DNA (Freeman and Yamamoto, 2002; Kang
et al., 1999; Stavreva et al., 2004). In both cases, HSP90 is
involved in the highly dynamic process of steroid receptor
binding to DNA, which implies that it also influences transactiva-
tion activity and possibly also degradation of receptors.
Furthermore, homodimerization of MR seems to occur as
soon as MR is released from HSP90, even in the cytosol and
therefore independently of DNA. The observation that dissocia-
tion of steroid receptor from HSP90 is a prerequisite for homodi-
merization is shared by Savory et al., who found that in-vitro-
translated GRs form dimers independently of added DNA and
that dissociation of MR from the chaperones by treatment with
0.4MNaCl also leads to formation of dimers even in the absence
of ligand (Savory et al., 2001). In our experiments, geldanamycin-
induced cytosolic dimers did not lead to transactivation. Like-
wise, a divalent antibody enforcing progesterone receptor
dimerization is able to promote DNA binding in the absence of
ligand in vitro, but it cannot induce transcription (Allan et al.,
1992). Overall, two kinds of dimers seem to form after dissocia-
tion fromHSP90; however, only the dimers formed in the nucleus
after ligand binding seem to be genomically functionally active.
As another substance, the MR antagonist spironolactone
was tested in our experiments. Spironolactone prevented both
nuclear translocation and dimerization assessed by eBRET.
Similar results have been reported by others, thus showing a
distinct behavior of antagonists versus agonists at steroid recep-
tors (Couette et al., 1998; Fejes-To´th et al., 1998; Huyet et al.,
2007; Lombe`s et al., 1994; Tsai and O’Malley, 1994).
In our transcription factor ELISAs, geldanamycin reduced
binding of MR to DNA while the binding of GR was not affected.
Nevertheless, HSP90 enhances DNA binding of MR without
being bound to DNA itself. A possible mechanistic explanation
for this is the metastable structure of the N-terminal domain of
steroid receptors (Bain et al., 2007). While smaller receptors
like the hGR, with its 440-amino-acid (aa)-long N terminus,
only require HSP90 for their stabilization in the cytosol, the larger
hMR, with its 602-aa-long N terminus, presumably is more
unstable and therefore requires the support of HSP90 for stabi-
lization in both cytoplasm and nucleus until it is bound to DNA.748 Chemistry & Biology 19, 742–751, June 22, 2012 ª2012 ElsevierOur findings conflict with previous results acquired by chromatin
immunoprecipitation showing an interaction between GR and
promoter of GRE liver genes. This discrepancy may arise from
the different experimental settings. Our ELISA was performed
in vitro with oligonucleotides containing only GRE. Possibly,
a longer sequence would be needed for HSP90 association.
Additionally, our in vitro system might lack cofactors necessary
for binding of HSP90. Although binding of MR and GR to DNA
does not depend on the presence of ligand, no transactivation
of GR orMR occurs without ligand or after incubation with gelda-
namycin, because no facilitated translocation into the nucleus is
possible in the absence of ligand or HSP90 (Figure 1A) (Nemoto
et al., 1993).
Taken together, our results support the following model of MR
activation (Figure 7): in its inactive form, the MR is located in the
cytoplasm associated with HSP90 and other chaperones. At this
time point, the chaperones are necessary to prevent MR degra-
dation and to keep the MR in a form able to bind ligand. Upon
ligand binding (1), a change in associated proteins takes place
and the MR travels to the nucleus bound to HSP90 (2). Of
note, nuclear trafficking has been also described in the absence
of HSP90 but then occurs much slower (Galigniana et al., 2010).
In the nucleus, HSP90 facilitates binding of the MR to DNA and
then dissociates from the MR (3). Dissociation of HSP90 is
a prerequisite for MR homodimerization. However, only homo-
dimers formed in the nucleus seem to be able to regulate gene
expression, while those formed in the cytoplasm after incubation
with geldanamycin (4) do not possess the ability to translocate to
the nucleus and influence transactivation (5). HSP90, therefore,
is important for nuclear transport, and its absence is a prerequi-
site for dimerization. HSP90 itself does not bind to the DNA and
presumably is recycled to the cytoplasm after binding of
receptor to DNA. Ligand, on the other hand, seems to be neces-
sary for the HSP90-dependent transport of MR into the nucleus
but is not necessary for DNA binding. While HSP90 furthers the
binding of MR to DNA, it does not affect DNA binding of GR.Ltd All rights reserved
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element but elicit very different effects, such differences are
interesting for explaining MR specificity. Gaining further insights
into non-classical MR signaling is of value to understand the
mechanisms of the pathophysiological effects of the MR with
the option of therapeutical intervention.
SIGNIFICANCE
In the present study, we mechanistically investigate the
genomic signaling of steroids via nuclear receptors using
aldosterone and the mineralocorticoid receptor (MR). Origi-
nally, the MR was thought to be important mainly for water-
electrolyte homeostasis. New interest in MR signaling arose
recently when clinical studies and experimental data dem-
onstrated that the MR can convey pathophysiological
effects including inflammation, remodeling, and endothelial
dysfunction in the cardiovascular system and the kidneys.
Nevertheless, the underlying mechanism for these patho-
physiological MR effects is still unclear. Additionally, the
mechanism for MR specificity over its closest relative the
glucocorticoid receptor with which it shares a common
hormone response element needs to be elucidated. We
found that upon ligand binding, the MR shuttles into the
nucleus and that during trafficking binding of MR to HSP90
is detectable both in the cytosol and the nucleus. MR homo-
dimerization requires dissociation from HSP90 and is pos-
sible in the cytoplasm (induced by geldanamycin) and the
nucleus (physiological). However, only the nuclear formed
MR dimers induce transactivation at the hormone response
element. Aldosterone, the endogenous MR ligand, initiates
nuclear translocation but is not necessary for DNA binding
of MR in an in vitro system. HSP90, on the other hand,
furthers binding ofMR toDNAbut does not influence binding
of the closely related glucocorticoid receptor, which is in-
formation of interest when investigating MR specificity.
Overall, these findings contribute to the mechanistic under-
standing of the signaling of steroid receptors and facilitate
the investigation for potential cytoplasmic interaction part-
ners of the MR. This is of special interest for solving the
enigma of MR specificity and to understand and ultimately
develop strategies to prevent pathophysiological aldoste-
rone effects.
EXPERIMENTAL PROCEDURES
Cell Culture and Vectors
HEK293 cells lacking MR expression were acquired from ATCC (Rockville,
MD) and cultivated in DMEM/Ham’s F-12 medium supplemented with 10%
fetal calf serum at 37C with 5% CO2. Transient transfections were performed
with Polyfect Reagent (QIAGEN), according to themanufacturer’s instructions.
Prior to experiments, cells were made quiescent by incubation in medium
without serum or supplements for at least 24 hr.
pRLucC1 vector was purchased from Perkin Elmer. MR from pEGFP-hMR
(a kind gift of N. Farman) was cloned into pRLucC1 with BglII and HindIII,
into pDsRED2-N1 (Clontech) with BglII and KpnI to obtain pRFP-MR, into
pEYFP-C1 (Clontech) with BglII and SacII to construct pEYFP-MR, and into
pcDNA3.1HisC (Invitrogen) after restriction with BglII/BamHI and HindIII to
acquire pcDNA3.1HisC-MR. We constructed pcDNA3.1His-GR by restricting
pcDNA1-GR (a kind gift from M. Govindan) with EcoRI and cloning the frag-
ment into pcDNA3.1HisB (Invitrogen). To obtain stable pRLuc-MR clones,Chemistry & Biology 19,HEK cells were transiently transfected with pRLuc-MR, selected with G418
(600 mg/l), and cloned by dilution.
Cell Fractionation
Cells were cultivated in 10 cm culture dishes and transfected with
pcDNA3.1HisC-MR and pcDNA3.1HisB-GR. After 48 hr under quiescent
conditions, cells were incubated with vehicle, aldosterone (10 nM), or dexa-
methasone (100 nM) for 1 hr. The isolation of the nuclear and cytoplasmatic
extracts were performed using the Nuclear Extract Kit from Active Motif as
recommended by the manufacturer. The protein content was determined
using Bradford reagent.
Western Blot
Cells were washed, harvested, and lysed in Cell Signaling Technology (CST)
buffer (20 mM Tris HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% Triton X-100, 2.5 mM sodium pyrophysphate, 1 mM Na3VO4) supple-
mented with protease inhibitor cocktail I from Calbiochem. Subsequently,
cell lysates were matched for protein content, separated by SDS-PAGE,
and transferred to polyvinylidene fluoride (PVDF) membrane. Membranes
were blotted with the respective antibodies (rMR1-18, DSHB; anti-GR, Santa
Cruz; anti-HSP90, Santa Cruz; anti-Xpress, Invitrogen for pcDNA3.1HisMR,
pcDNA3.1HisGR, and pcDNA3.1HisLacz).The bound primary antibody was
visualized using horseradish peroxidase-conjugated secondary immunoglob-
ulin G and the ECL system (Amersham Corp.). For the detection of western
blots, the ChemiDoc XRS gel documentation system from Biorad was used
together with the Quantity One software for quantification of bands. Only
signals obtained within the linear range were analyzed.
Coimmunoprecipitation
Cells were transfected with EGFP or EGFP-hMR and then incubated with aldo-
sterone or vehicle for the indicated amounts of time. Coimmunoprecipitations
were performed with GFP-coupled microbeads and m columns from Miltenyi
as recommended by the manufacturer. Lysates from whole cells or nuclear
extracts were used as indicated. Proteins were eluted from the columns and
detected by western blot.
ELISA-Based Transcription Factor DNA Binding Assay
In-vitro-synthesized MR, GR, and Lacz (as a negative control) were synthe-
sized using the TNT T7 Quick Coupled Transcription/Translation system
(Promega). GRE probe was hybridized from biotinylated GRE oligonucleotides
(sense: 50-Biotin ctagcggtacattttgttctagaac-30; antisense: Biotin-50 gttctagaac
aaaatgtaccgctag-30 ) and was then immobilized in streptavidin-coated wells.
Subsequently, hMR, hGR, or Lacz was added to the wells and incubated for
1 hr at room temperature with blocking buffer (5% bovine serum albumin
[BSA] in PBS/Tween 0.05%). After three washes, the transcription factor or
LacZ bound to the biotinylated GRE probe was detected by using a specific
anti-XPRESS antibody (1:2,000; Invitrogen) and a horseradish peroxidase-
coupled secondary antibody followed by a specific colored substrate reaction
with o-phenylenediamine.
Fluorescence Microscopy
Cells were cultivated on coverslips and analyzed using an invertedmicroscope
(Zeiss Axiovert 135) equipped with 403 and 1003 flurorescence objectives.
Images were obtained using an intensified charge-coupled device camera
(Hamamatsu, Herrsching, Germany). Time lapse experiments and immunoflu-
orescence images were analyzed with a Biozero 8000 fluorescence micro-
scope from Keyence (Tokyo, Japan).
Time Lapse Experiments
Time lapse experiments were performed in an incubation chamber in microd-
ishes (IBIDI) in HEPES buffer with a digital BZ-8000 fluorescence microscope
with integrated camera and corresponding software from Keyence (Osaka,
Japan).
Immunofluoresence
HEK cells were cultivated on glass coverslips, fixed with 4% formaldehyde
(15 min), washed with PBS, and permeabilized with 0.5% Triton X-100.
Subsequently, cells were incubated for 10 min in 1% SDS/PBS, followed by
10 min in 100 mmol/l glycine/PBS, and finally, 20 min in 10% serum/1%
BSA/PBS. After 60 min incubation with anti-HSP90 (Santa Cruz), cells were742–751, June 22, 2012 ª2012 Elsevier Ltd All rights reserved 749
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secondary antibody and washed again with PBS. Subsequently, DAPI staining
was performed. Cells were analyzed with the z-stack function of the Biozero
8000 fluorescence microscope from Keyence.
eBRET
For eBRET, stable pRLuc-hMR clones were seeded in 96-well plates and
transiently transfected with pEYFP-hMR or pcDNAHisC-MR as described
earlier. Prior to experiments, cells were cultivated in medium without supple-
ments for 24 hr. For eBRET itself, cells were incubated with 60 mM EnduRen
in Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F12 medium without
supplements. After 90 min incubation time, basal luminescence was
measured; vehicle (dimethyl sulfoxide; DMSO), 10 nM aldosterone, 100 nM
spironolactone, or 4 mM geldanamycin was added; and further luminescence
measurements were performed for up to 105 min with a 535 nm and a 460 nm
filter in a multilabel counter (Victor2, Wallac). Final concentration of DMSO
added to the cells was %1:1,000. To take into account the overlap between
emission and excitation spectra of donor and acceptor entities, BRET
measurements were performed as BRET ratios (emission EYFP [535 nm]/
emission RLuc [460 nm]). This eliminates variations in cell numbers per well,
expression of proteins, and substrate concentrations. To account for spillover
of light, the ratio emission (535 nm)/emission (460 nm) of donor-only trans-
fected cells was subtracted (Pfleger and Eidne, 2006).
FRET
Cells were cultivated in 96-well plates and transfectedwith EYFP-MRandRFP-
MR. After 48 hr, cells were incubated with vehicle, 10 nM aldosterone, or 2 mM
geldanamycin for the indicated time span. Subsequently, cells were washed
with PBS and fixed (4% paraformaldehyde, 60 min at 21C). Fluorescence
values (Fexcitation/emission) were then measured using the Infinite 200 Multiwell
Reader (Tecan): F490/535 (Em1 for EYFP), F558/580 (Em2 for RFP) and F490/580
(Em3 for FRET determination). The excitation and emission wavelengths
were set by two prisms with a bandpath of 2 nm for excitation and 15 nm for
emission. FRET efficiency was calculated from the fluorescence values after
background subtraction as described previously (Grossmann et al., 2010).
Images for single-cell FRET were obtained with a Biozero 8000 fluorescence
microscope from Keyence (Tokyo, Japan). The FRET image was calculated
using the mean bleed through coefficient determined in the bleed through inlet
for both the donor alone and the acceptor alone according to the FRET analyzer
for ImageJ (http://rsbweb.nih.gov/ij/plugins/fret-analyzer/fret-analyzer.htm).
SEAP Reporter Gene Assay
The effect of geldanamycin on GRE transactivation and the function of both
RLuc-MR and EYFP-MR were tested in a reporter gene assay as described
previously (Pfau et al., 2007).
Statistics
The data are presented as mean values ± SEM. Significance of difference was
tested by Student t test or an analysis of variance, with p < 0.05 considered
statistically significant. N represents the number of individual experiments,
and n represents the number of wells or culture dishes investigated per
experiment.
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